Jim Tananbaum is the founder of Foresite Capital. Foresite Capital is an organization in the health industry. Foresite partners with other health investors to help improve the health and well-being of individuals. Currently, Foresite Capital has started a healthcare project focused on the use of smart phones in the diagnosis and treatment of neuropsychiatric problems. The project is known as Mindstrong Health.
According to pelotontherapeutics.com, at the moment, Mindstrong Health has set aside $14 million to aid in its activities. The source of the fund is from a series of health investors. The investor companies include Foresite Capital, Optum Ventures, ARCH Venture Partners and One Mind Brain Health Impact Fund. Together, the organizations seek to provide support to Mindstrong Health to aid in the realization of good health.
Mindstrong Health’s specialty is in mental disorders. According to Paul Dagum, Mindstrong Health’s technology will deliver measures to the resolutions of cognitive disorders. Dagum postulates that people with mental ailment need the same kind of treatment designed for people with chronic illness like diabetes and heart disease.
Mindstrong Health platform is designed to use smart phones in monitoring of brain functions. The use of the smart phone is quite easy. The patient way of scrolling and how they type on the smart phone is used to measure the functioning of the brain. After that, the phone provides the brain’s situation by giving the mood and biomarkers of cognition. The cognition biomarkers include information on the memory and brain’s processing speed.
The founding team of Mindstrong Health will provide unmatched recognition on the challenges facing the medical community. The experts will work together using their collective experience and vision to improve the mental patients’ outcomes. Tananbaum states that Mindstrong platform will enhance how care is provided to people with a mental health condition.
Jim Tananbaum has led investments in numerous companies. Over time, Jim has been attributed to 21 successful healthcare ventures including Amira Pharmaceuticals, Jazz Pharmaceuticals, and Amerigroup. Before founding Foresite, Tananbaum established the GelTex Pharmaceuticals and Theravance.
Jim Tananbaum attended university at the Harvard Medical School and Harvard Business School. Later, Jim earned a B.S and B.S.E.E from the University of Yale. Jim has served on the Harvard-MIT HST in the advisory boards. He has also been named as part of Forbes Midas 100 according to Inc.42.